Oxygen Delivery Notes

Oxygen Therapy Overview

  • Definition: The administration of oxygen at concentrations greater than ambient air to treat or prevent symptoms of hypoxia (AARC).

  • Clinical Principles:     * Oxygen is classified as a drug and must be prescribed with target saturations.     * Used to treat hypoxaemia, not breathlessness.     * Monitoring is conducted via pulse oximetry, ABG results, and the NEWS2-obs chart.     * Inappropriate administration (excessive or insufficient) can be harmful.

Oxygen Supply Methods

  • Sources: Piped wall supply, oxygen cylinder, and oxygen concentrator.

  • Connectors/Tubing: Tubing varies in diameter (5 mm5\,mm to 22 mm22\,mm) and length (1.81.8 to 4 m4\,m).

Variable Performance Systems

  • Supplemental Oxygen Approximates:     * Room air: ≈21%\approx 21\% oxygen.     * 1 lpm1\text{ lpm}: ≈24%\approx 24\% oxygen.     * 2 lpm2\text{ lpm}: ≈28%\approx 28\% oxygen.     * 3 lpm3\text{ lpm}: ≈32%\approx 32\% oxygen.     * 4 lpm4\text{ lpm}: ≈36%\approx 36\% oxygen.

  • Nasal Cannula:     * Pros: Used for long-term therapy or stable post-operative patients; allows eating, drinking, and speaking.     * Cons: Flows over 4 lpm4\text{ lpm} are uncomfortable; risk of nasal mucosa trauma; FiO2\text{FiO}_2 is variable based on respiratory rate (RR).

  • Simple Face Mask:     * Cons: Must be set over 5 lpm5\text{ lpm} to prevent CO2CO_2 retaining; concentration is variable.

  • Non-Rebreather Mask:     * Flow Rate: Must be 1010 to 15 lpm15\text{ lpm} to avoid reservoir bag collapse.     * Concentration: Delivers high levels (≈60-85%+\approx 60\text{-}85\% \text{+}).

Fixed Performance Systems (Venturi)

  • Mechanism: Uses the Bernoulli principle to deliver a fixed concentration of oxygen by entraining ambient air.

  • Predetermined Concentrations:     * 2 lpm2\text{ lpm}: 24%24\%     * 4 lpm4\text{ lpm}: 28%28\%     * 6 lpm6\text{ lpm}: 31%31\%     * 8 lpm8\text{ lpm}: 35%35\%     * 10 lpm10\text{ lpm}: 40%40\%     * 15 lpm15\text{ lpm}: 60%60\%

  • Indications: Patients with chronic lung disease and CO2CO_2 retention who rely on Hypoxic Drive.

Hypoxic Drive and CO2CO_2 Retention

  • Mechanism: Chronic elevation of CO2CO_2 levels (e.g., emphysema) renders medullary chemoreceptors insensitive to high PCO2PCO_2. Respiration is instead stimulated by very low PO2PO_2 levels sensed by peripheral chemoreceptors.

  • Clinical Risk: Over-oxygenation can produce respiratory depression and increased CO2CO_2 retention.

Humidification and High Flow Therapy

  • Humidification: Prevents drying of respiratory epithelium and mucus, which can impair the mucociliary escalator and cause infection or airway obstruction.

  • High Flow Nasal Cannula (HFNC):     * Delivers heated/humidified gas up to 60 L/min60\text{ L/min}.     * Washes out CO2CO_2 in physiological dead space.     * Offers constant FiO2\text{FiO}_2 from 0.210.21 to 1.01.0.     * Provides Positive End Expiratory Pressure (PEEP), increases tidal volume, and reduces RR.